It seems that some disclosures of classified information can lead a person to poverty, ignominy and a jail sentence, while others provide a royal road to fame and fortune. Some leaks are relentlessly investigated, while others are tolerated or encouraged.
This apparent inconsistency, as notably illustrated once again in the phenomenon of author Bob Woodward, was examined by Michael Isikoff in “‘Double standard’ in White House leak inquiries?”, NBC News, October 18.
In the wake of an earlier Woodward book in 2007, Rep. Henry Waxman noted a similar discrepancy in the Bush Administration’s response to leaks.
“The administration seems to be inconsistent in their approach in these cases, and it’s troubling,” Rep. Waxman said at a March 16, 2007 hearing. “They raise very serious questions about whether White House policies on sensitive information are driven by political considerations. If it’s a critic [who discloses classified information] they are going to investigate, they’re going to really stop it. When it comes to people in-house, people they like, people they trust, well, the investigation hasn’t even started with regard to those people.”
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.